Stakeholder Perspectives on Ethical Challenges in HIV Vaccine Trials in South Africa
Quayle, Michael Milford, Cedilia
Developing world bioethics 2010 Apr ; 10(1): 11-21
There is little published literature on the ethical concerns of stakeholders in HIV vaccine trials. This study explored the ethical challenges identified by various stakeholders, through an open-ended, in-depth approach. While the few previous studies have been largely quantitative, respondents in this study had the opportunity to spontaneously identify the issues that they perceived to be of priority concern in the South African context. Stakeholders spontaneously identified the following as ethical priorities: informed consent, social harms, collaborative relationships between research stakeholders, the participation of children and adolescents, access to treatment for participants who become infected with HIV, physical harms, fair participant and community selection, confidentiality, benefits, and payment. While there is some speculation that research in developing countries poses special ethical challenges, overall no issues were identified that have not been anticipated in international guidance, literature and popular frameworks. However, the South African context affords a distinctive gloss to these expected issues; for example, respondents were concerned that the predominant selection of black participants may perpetuate racist practices of apartheid. Stakeholders should be aware of contextual factors impacting on the implementation of ethical principles. We make a series of recommendations for South African trials, including amendments to the ethical-legal framework and research policies, and, for further research.
Adolescents; Children; Confidentiality; Consent; Developing Countries; Informed Consent; Literature; Research; Stakeholders; Drugs and Drug Industry; Human Experimentation Policy Guidelines / Institutional Review Boards; International and Political Dimensions of Biology and Medicine; Acquired Immunodeficiency Syndrome or HIV Infection;
Showing items related by title, author, creator and subject.
HIV Prevention Responsibilities in HIV Vaccine Trials: Complexities Facing South African Researchers Essack, Zaynab; Slack, Catherine; Koen, Jennifer; Gray, Glenda (2010-01)Researchers should protect the welfare of research participants through providing methods to reduce their risk of acquiring HIV. This is especially important given that late-phase HIV vaccine trials enrol HIV-uninfected ...
Koen, Jennifer; Slack, Catherine; Barsdorf, Nicola; Essack, Zaynab (2008-12)
Convergent Ethical Issues in HIV/AIDS, Tuberculosis and Malaria Vaccine Trials in Africa: Report From the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre Consultation, 10-11 February 2009, Durban, South Africa Mamotte, Nicole; Wassenaar, Douglas; Koen, Jennifer; Essack, Zaynab (2010)BACKGROUND: Africa continues to bear a disproportionate share of the global HIV/AIDS, tuberculosis (TB) and malaria burden. The development and distribution of safe, effective and affordable vaccines is critical to reduce ...